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ABSTRACT 
 
 
D2 Dopamine Receptor Mediation of Risky Decision-making. (May 2010) 
Nicholas Wayne Simon, B.A., Carthage College; 
M.S., Western Illinois University 
Chair of Advisory Committee: Dr. Barry Setlow 
 
 Excessive risk-taking is a characteristic of several psychopathological 
disorders. In order to alleviate maladaptive risky behavior, a thorough 
understanding of the neurobiological and pharmacological substrates of risky 
choice must be developed. In this dissertation, the “risky decision-making task” 
was utilized to explore the mechanisms by which dopamine mediates risky 
choice.  
In experiment 1, we characterized rats in risky decision-making as well as 
a variety of other behavioral traits. This was performed to determine if the 
behavioral patterns obtained in the risky decision-making task represent an 
independent cognitive construct rather than a function of a separate behavioral 
trait. Risky decision-making performance was not correlated with measures of 
motivation, anxiety, pain tolerance, or other types of decision-making. In contrast, 
risky choice was correlated with impulsive action as assessed by the Differential 
Rates of Low Responding Task, suggesting that risky choice may be 
mechanistically similar to impulsive action. 
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In experiment 2, the effects of various dopaminergic drugs on risky 
decision-making was investigated. Amphetamine administration attenuated risky 
choice, while the dopamine antagonist α-flupenthixol had no effect on risky 
choice. Agonists and antagonists specific to D1 dopamine receptors had no 
effects on risky choice; however, the D2 dopamine receptor agonist 
bromocriptine reduced risky choice in a manner similar to amphetamine. 
Furthermore, co-administration of amphetamine with a D2 antagonist abolished 
amphetamine’s effects on risky choice, and amphetamine’s effects were 
unaffected by coadministration of a D1 antagonist. These data suggest that D2 
signaling at the receptor is particularly critical to risky decision-making behavior.          
 In experiment 3, D2 dopamine receptor mRNA abundance was assessed 
in rats that had been previously characterized in risky decision-making using in 
situ hybridization. Levels of D2 cRNA hybridization in both orbitofrontal cortex 
(OFC) and medial prefrontal cortex (mPFC) predicted risky decision-making 
behavior as assessed by nonlinear curve estimation analyses. Interestingly, 
opposite relationships between D2 mRNA abundance and risky choice were 
observed in these two cortical areas, with OFC D2 mRNA abundance showing a 
U-shaped relationship with risky choice, and mPFC D2 mRNA resembling an 
inverted U-curve. Additionally, increased levels of D2 mRNA in dorsal striatum 
were observed in risk-averse rats in comparison to risk-taking rats. In conclusion, 
these data suggest that signaling via D2 dopamine receptors is an important 
mediator of risky decision-making behavior, and that D2 signaling in frontostriatal 
circuitry may be particularly relevant toward these behaviors. 
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INTRODUCTION 
 
 Throughout each day, people are faced with situations that require quick 
and effective decisions. The majority of these decisions require the careful 
assessment of an array of outcomes before determining which option is the most 
beneficial. Often, a subjectively favorable outcome is accompanied by some 
degree of risk. For example, exceeding the speed limit can confer benefits, such 
as arriving at one’s destination sooner. However, there is also probability that this 
behavior will result in a citation for speeding that varies based on time of day, 
neighborhood, weather, or other factors. In order to make optimal decisions, 
people must be aware of surrounding contingencies and adjust their behavior 
accordingly. An inability to appropriately assess risky situations can lead to social 
problems, financial instability, and injury. 
  Individuals with various psychopathological and somatic disorders such 
as ADHD, schizophrenia, major depressive disorder, drug addiction, and 
Parkinson’s disease demonstrate maladaptive risky decision-making (Bechara et 
al 2001; Drechsler et al. 2008; Ernst et al. 2003; Heerey et al. 2008; Kobayakawa 
et al. 2008; Ludewig et al. 2003; Taylor Tavares et al. 2007). A common 
pathology underlying most if not all of these disorders is abnormal dopamine 
transmission. In addition, healthy individuals subjected to dopamine depletion 
demonstrate increased risky choice (Sevy et al. 2006). Therefore, an 
understanding  of  the   specific   method   by   which   dopamine   mediates  risky 
 
___________ 
This dissertation follows the style of Annual Review of Neuroscience. 
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decision-making is important for the treatment of excessive risk-taking. The 
development of an animal model that is both reliable and possesses face validity 
as a model of complex risky decisions is critical for the delineation of the 
pharmacological and neural substrates involved with risky choice. 
  Unfortunately, although there are several reliable models of animal 
decision-making that have been well-characterized (for reviews see Cardinal 
2006; Floresco et al. 2008), there are few that integrate rewarding outcomes with 
the risk of a punishing stimulus. To fill this void, we developed a task in which 
rats choose between a small, safe food reward and a large, risky food reward 
that is associated with a systematically increasing probability of punishment 
(footshock). It was observed that rats performing this “risky decision-making” task 
display a shift in behavioral preference from the risky to safe reward as the risk of 
punishment increases, and that performance in this task remains reliable over 
long periods of time (Simon et al. 2009). Interestingly, a trend that persisted 
throughout several cohorts of rats was the presence of a subset of rats that can 
be characterized as “risk-taking”, showing an almost 100% preference for the 
risky reward. This phenotype could prove exceptionally useful as a model of 
pathological risk-taking.   
 However, the utility of the risky decision-making task is contingent upon 
the construct of “risk” existing as an independent trait rather than as an artifact of 
a separate behavioral construct or an aggregate of various behavioral factors. In 
other words, rats’ willingness to risk punishment as assessed by the risky 
decision-making task could simply be governed by a combination of behavioral 
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constructs such as pain tolerance and reward motivation. Experiment 1 of this 
dissertation addressed this concern by characterizing rats on the risky decision-
making task, then testing the same rats on measures of several additional 
behavioral constructs that may influence or share variance with risky decision-
making performance. Behavior was measured in three other cost-benefit 
decision-making tasks: probabilistic discounting, which measured the degree to 
which risk of reward omission (rather than physical punishment) discounts 
reward value (St Onge & Floresco 2009); delay discounting, which measured 
willingness to tolerate delayed rewards (Evenden & Ryan 1996), and effort-based 
discounting, which measured rats’ willingness to exert effort for large rewards 
(Ghods-Sharifi et al. 2009). Several other traits that may influence risky decision-
making performance were also assessed, including multiple measures of 
motivation, pain sensitivity, and impulsive action (the inability to withhold a 
prepotent motor response). The relationships between these data and risky 
decision-making performance as well as with performance on the other cost-
benefit decision-making tasks were then analyzed. 
 Experiment 2 consisted of a series of pharmacological experiments 
designed to test the influence of acute administration of various dopaminergic 
agents on risky decision-making. Acute systemic injections of amphetamine, 
flupenthixol (a non-specific dopamine receptor antagonist) and D1 and D2 
dopamine receptor specific agonists and antagonists were all administered prior 
to testing. There is prior evidence that amphetamine decreases risky decision-
making (Simon et al. 2009); in order to delineate the dopamine receptor subtype 
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that specifically mediates the effects of amphetamine, amphetamine was co-
administered with antagonists specific  for each receptor subtype.   
 Experiment 3 tested the hypothesis that baseline differences in dopamine 
receptor level account for some of the variability observed in risky decision-
making. This was achieved by performing in-situ hybridization to measure mRNA 
for the specific dopamine receptor subtype (D2) found to mediate risky decision-
making in Experiment 2. The untreated rats previously characterized in risky 
decision-making as well as the other cost-benefit decision-making tasks and 
behavioral control measures (Experiment 1) were used for this experiment to 
allow the comparison between multiple behavioral measures and dopamine 
receptor mRNA. In-situ hybridization offered the advantage of brain region-
specific analysis; the areas in which mRNA was quantified were the orbitofrontal 
cortex, medial prefrontal cortex, dorsal striatum, and nucleus accumbens, all 
brain regions shown previously to contribute to reward- and punishment- related 
decision-making (Bechara et al. 2000; Cardinal 2006; Clark et al. 2008; Morrison 
& Salzman 2009; Naqvi & Bechara 2009; Roesch et al. 2007a; St. Onge & 
Floresco 2009; Winstanley et al. 2004b; Winstanley et al. 2006).  
 
 
 
 
5 
 
METHODS 
Experiment 1: The Relationship between Risky Decision-making and Other 
Behavioral Measures 
Subjects 
 Male Long-Evans rats (n=18; Charles River Laboratories, Raleigh, NC 
weighing 275-300 g upon arrival) were individually housed and kept on a 12 hour 
light/dark cycle (lights on at 0800) with free access to food and water except as 
noted.  All procedures were conducted in accordance with the Texas A&M 
University Laboratory Animal Care and Use Committee and NIH guidelines. 
Behavioral Testing 
Decision-making Tasks 
Risky Decision-making Task 
Shaping procedures were identical to those used previously (Simon et al. 
2007). Following magazine training, rats were trained to press a single lever 
(either left or right, counterbalanced across groups; with the other retracted 
during this phase of training) to receive a single food pellet. After reaching a 
criterion of 50 lever presses in 30 minutes, rats were shaped to press the 
opposite lever under the same criterion. This was followed by further shaping 
sessions in which both levers were retracted and rats were shaped to nose-poke 
into the food trough during simultaneous illumination of the trough and house 
lights. When a nose-poke occurred, a single lever was extended (left or right), 
and a lever press resulted in immediate delivery of a single food pellet. 
Immediately following the lever press, the house and trough lights were 
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extinguished and the lever was retracted. Rats were then trained to a criterion of 
at least 30 presses of each lever in 60 minutes. This shaping procedure was 
sufficient for all three decision-making tasks. 
Test sessions were 60 minutes long and consisted of five blocks of 18 
trials each. Each 40 s trial began with a 10 s illumination of the food trough and 
house lights. A nose poke into the food trough during this time extinguished the 
food trough light and triggered extension of either a single lever (forced choice 
trials) or of both levers simultaneously (choice trials). If the rats failed to 
nosepoke within the 10 s time window, the lights was extinguished and the trial 
scored as an omission. 
A press on one lever (either left or right, balanced across animals) 
resulted in one food pellet (the small, safe reward) delivered immediately 
following the lever press. A press on the other lever resulted in delivery of three 
food pellets (the large reward). However, selection of this lever was also 
accompanied immediately by a possible 1 s footshock contingent on a preset 
probability specific to each trial block. The probability of footshock accompanying 
the large reward was set at 0% during the first 18-trial block. In subsequent 18-
trial blocks, the probability of footshock increased to 25, 50, 75, and 100%. Each 
18-trial block began with 8 forced choice trials used to establish the punishment 
contingencies (4 for each lever), followed by 10 choice trials (Cardinal & Howes 
2005; St Onge & Floresco 2009). Once either lever was pressed, both levers 
were immediately retracted. Food delivery was accompanied by re-illumination of 
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both the food trough and house lights, which was extinguished upon entry to the 
food trough to collect the food or after 10 s, whichever occurred sooner. 
 Locomotor activity was assessed during each shock presentation and 
averaged across the entire session for each subject. This measure of shock 
reactivity was utilized as an assessment of pain tolerance to be compared with 
the other tasks. 
Probabilistic Discounting 
The parameters of this task were identical to the risky decision-making 
task, with the main difference following selection of the large reward lever. During 
the first block of trials, the large reward was delivered with 100% probability. 
During each of the four subsequent blocks, the probability of large reward 
delivery was systematically decreased (50, 25, 12.5, 0%). The large reward was 
accompanied by neither punishment nor a delay period. Each block was 
preceded by 8 forced choice trials with equal random presentations of each lever, 
and each trial lasted for 40 seconds. Each full session lasted 60 minutes.   
Delay Discounting 
 For a detailed version of this task methodology, see Simon et al. (2007). 
Delay discounting task design resembled the risky decision-making task, with the 
critical difference being the reward delivery associated with the large reward 
lever. Selection of this lever again resulted in 3 food pellets, but during this task, 
reward delivery was preceded by a delay (with no risk of footshock). The delay 
escalated with each 10-trial block (0, 4, 8, 16, and 32 s). Each trial lasted 60 
seconds, and each session lasted 60 minutes.  
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Effort-based Discounting 
This task was modified from Floresco et al. (2007). The basic parameters 
were similar to the previous decision-making tasks, with exceptions for reward 
size and the criterion required to obtain the large reward. A lever press on the 
small reward lever caused delivery of 2 food pellets immediately. Selection of the 
large reward lever caused the small reward lever to retract and the large reward 
lever to remain extended; from that point, multiple lever presses were required to 
achieve fulfillment of an effort-based criteria. After the criterion was met, both 
levers were retracted and 4 food pellets were delivered. The effort criteria for the 
5 blocks were 1, 2, 4, 8, and 16 lever presses. Each session lasted 60 minutes.  
Motivation Assessment Tasks 
Sucrose Consumption 
 
Rats were given access to daily 30-min tests for separate concentrations 
of sucrose solutions (0, 2.5, 5, 10, 20% in tap water; counterbalanced order) 
while in their home cages. Sucrose consumption was measured by weighing 
each sucrose container before and after each test session. This measure was 
used as a measure of reward motivation. 
Fixed Ratio and Progressive Ratio Responding 
 
 Rats were again food restricted to 85% of their free feeding weight prior to 
testing. Motivation for food reward was assessed daily using 30 minute fixed ratio 
(FR) schedules (FR1, 3, 10, 20, 40). Following FR testing, motivation was 
assessed further using a progressive ratio schedule of reinforcement, on which 
the number of lever presses required to earn a reward increased with each 
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successive reward earned (1, 4, 10, 20, 35, …) (Mendez et al. 2009). These 
sessions varied in length, ending only after an hour with no reward delivery had 
passed (the breakpoint).  
Pain Tolerance Assessment Tasks 
Shock Locomotion 
 
 This measure of shock reactivity was acquired during performance of the 
risky decision-making task. During the 1-s footshock that followed selection of the 
large, risky reward, overall locomotor activity was measured, and an average of 
these scores was used as a measure of shock sensitivity (Chhatwal et al. 2005; 
Simon et al. 2009).  
Tail Flick Test 
An IITC Model 33A tail-flick apparatus were used as a measure of pain 
tolerance (Mendez & Trujillo 2008). This device focused a hot lamp on the tail of 
the animal, between 2 and 8 centimeters from the tip. The amount of time before 
each subject moved its tail from the heat was automatically recorded. A heat 
setting that yielded a 3-6 second baseline response was used, and an automatic 
cut off time of 10 seconds was set to avoid any tissue damage. Tail flick latency 
was determined by taking the mean of three tail flicks, separated by 15-20 
seconds. These data were used as a measure of pain sensitivity. 
Shock Sensitivity Testing 
 
 This procedure was modified from King et al. (1996). First, rats were 
restrained in a plexiglass tube and habituated for 15 minutes. Shock sensitivity 
was assessed using a manual shocker (BRS/LVE, Model SG-903) that allowed 
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continuous variation of shock intensity between 0 and 2 mA. Test shocks were 
applied 7 cm from the base of the tail through electrodes constructed from 
lightweight fuse clips. Shock intensity was gradually increased at a rate of .05 mA 
every 3 seconds. Latency to movement and vocalization were then assessed, 
after which the shock was terminated. 
Anxiety-Assessment Tasks 
Elevated Plus Maze 
 The elevated (73 cm from the floor) plus-maze (EPM) consisted of two 
opposing closed arms and two opposing open arms (42.7 cm length × 15.2 cm 
width/arm; arm enclosure height: 22.9 cm), and a central platform. Each 10-min 
test period began with the rat facing the left open arm, with behavior recorded 
using a camera suspended over the maze. Following testing, the amount of time 
spent in the open arms and the amount of open arm entries was scored manually 
in order to formulate an anxiogenic profile for each subject (the amount of time 
spent in/entries into open arms was characterized as inversely related to general 
anxiety) (Schulteis et al. 1998; Wingard & Packard 2008). Total open and closed 
arm crossovers were also tabulated as a measure of general activity.   
Locomotion Test 
 
 Baseline locomotion and overall exploratory behavior were tested in 
activity monitoring chambers (Versamax System, Accuscan Instruments, 
Columbus, Ohio). Each chamber (40 x 40 x 30 cm) contained an array of 
photobeams used to detect movement in the horizontal plane throughout one 
hour-long session.  
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Impulsive Action Assessment Tasks 
Differential Reinforcement of Low Rates of Responding Task (DRL) 
 
 The DRL has been utilized as a measure of impulsive action, defined as 
the inability to withhold a prepotent motor response (Sokolowski & Salamone 
1994; Uslaner & Robinson 2006). Each DRL session was 45 minutes in length. 
Rats were trained on DRL-5s schedules for five days, during which a lever press 
only resulted in food pellet delivery if at least five seconds had elapsed since the 
previous press. Then, rats were trained for five days each on DRL-10s and DRL-
20s schedules. Finally, rats were given 15 days of training in a DRL-30s 
schedule. Impulsive action was assessed on day 15 as the ratio of unrewarded 
responses (lever presses during the 30 seconds after the previous, rewarded 
press) to total responses. 
Overall Experimental Timeline 
 
Risky decision-making (25 days) - Elevated plus maze (1 day) - Tail flick (1 day) - 
Locomotion (1 day) - Sucrose consumption (5 days) - Fixed ratio responding (5 
days) - Progressive ratio (1 day) - DRL(30 days) – Probabilistic discounting (20 
days) – Delay discounting (10 days) – Effort-based discounting (10 days) – 
Rebaseline risky decision-making (10 days) – Shock sensitivity testing (1 day) 
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Experiment 2: The Effects of Dopaminergic Manipulation on Risky Decision-
making  
Subjects 
A group of 12 male Long-Evans rats were used for amphetamine and 
flupenthixol treatment. A separate group of 12 male Long-Evans rats were used 
for all other treatment conditions. 
Drugs 
 The compound d-Amphetamine sulfate (Sigma, St. Louis MO; .33, 1.0, 1.5 
mg/kg) was selected as a dopamine enhancing drug, and α-flupenthixol (Sigma, 
.125, .25, .5 mg/kg) was used as a non-specific dopaminergic antagonist. 
SKF81297 (Tocris Bioservices, Ellisville, MO; 0.1, .3, 1.0 mg/kg) and SCH23390 
hydrobromide (Tocris; .005, .01, .03 mg/kg) were used as D1-specific agonist 
and antagonists, respectively. Bromocriptine mesylate (Tocris; 1.0, 3.0, 5.0 
mg/kg) was used as a D2-specific agonist, and eticlopride hydrochloride (Tocris; 
.01, .03, .05 mg/kg) was used as a D2 antagonist. All drugs were dissolved in 
0.9% saline vehicle expect the D2 agonist Bromocriptine, which was dissolved in 
dimethyl sulfoxide and then diluted at a 50:50 ratio with saline. Amphetamine and 
SKF81297 were administered 10 minutes prior to testing, SCH23390 and 
eticlopride were administered 20 minutes prior to testing, and bromocriptine was 
administered 40 minutes prior to testing (based on St. Onge et al., 2009). 
Experimental Procedure 
 Each drug treatment was administered on an eight day schedule, with 
injections on days 1, 3, 5, and 7. The three doses of drug and a saline treatment 
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were counterbalanced across these four days. There were no treatments on days 
2, 4, 6, and 8; these baseline days were used to confirm an absence of baseline 
shifts in behavior. Prior to each drug treatment regimen, rats were given a 
minimum of five days of baseline testing to ensure stable performance.  
Experiment 3: The Relationship between Dopamine Receptor mRNA and Cost-
benefit Decision-making 
Subjects 
 The same group of untreated, behaviorally characterized rats (n=18) 
utilized for Experiment 1 were used for this experiment. 
Tissue Preparation 
 Rats were sacrificed with a 100 mg/kg sodium pentobarbital solution, then 
perfused with 4% paraformaldehyde. Brains were removed and stored in 4% 
paraformaldehyde solution overnight, then post-fixed in 4% paraformaldehyde 
20% sucrose on the following day. The brains were sectioned (30 μm thickness) 
on the coronal plane, and were collected in a 1-6 series beginning at the anterior 
portion of prefrontal cortex (5.2mm Bregma), and ending posterior to the nucleus 
accumbens (-0.26 mm Bregma). For analyses, prefrontal cortex was divided into 
two subregions: orbitofrontal cortex (OFC),encompassing the orbitofrontal and 
insular cortices, and medial prefrontal cortex (mPFC), including infralimbic, 
prelimbic, and anterior cingulate cortex. The dorsal striatum (DS) and nucleus 
accumbens (NAcc) were also analyzed separately. 
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Probe Preparation 
The D2 cRNA probe consisted of 331 basepairs corresponding to 
basepairs atg (bps 416-18) through tga (bps 1748-50) of the full D2 receptor 
transcript. The cRNA probe was separated using an antisense T7 RNA 
polymerase transcribed in the presence of 35S-labelled UTP.  
In Situ Hybridization  
Free-floating sections of tissue were washed in 0.75% glycine in 0.1 M 
phosphate buffer,pH 7.2 (PB) and 0.1 M PB alone to remove excess fixative. 
Sections were treated for 30 min at 37 °C with proteinase K (1 mg/mL in 0.1 M 
Tris buffer containing 0.05% SDS), acetylated in 0.25% acetic anhydride in 0.1 M 
triethanolamine, pH 8.0, and rinsed twice in 2× saline sodium citrate buffer (SSC; 
1 × SSC = 0.15 M sodium chloride and 0.015 M sodium citrate, pH 7.0). Tissue 
was then hybridized for 42–44 h at 60 °C in solution containing 50% formamide, 
1 × Denhardt's solution, 10% dextran sulphate, 4 × SSC, 0.25 mg/mL yeast 
tRNA, 0.3 mg/mL herring sperm DNA, 100 mm dithiothreitol (DTT) and the 35S-
labelled D2 cRNA at a final concentration of 1 × 107 CPM/mL. Following 
hybridization, sections were washed at 30 min intervals, twice in 4 × SSC, once 
in 50% formamide/2 × SSC at 60 °C and then treated with ribonuclease A 
(20 mg/mL in 10 mM Tris saline buffer containing 1 mM ethylene-
diaminetetracetic acid) for 30 min at 37 °C. Tissue sections were then washed 
further in descending concentrations of SSC buffer containing 100 mM DTT to a 
final wash of 0.1 × SSC and mounted onto gelatin-coated slides for film 
autoradiography. Air-dried sections of the sections were exposed along with 14C-
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standards to phosphoimage screens (Perkin Elmer, Waltham MA). Because D2 
dopamine receptor mRNA is less abundant in prefrontal cortex than in striatum, 
brain sections containing prefrontal cortex were exposed for 72 hours, while the 
tissue containing DS or NAcc were exposed for 24 hours. Screens were scanned 
at high resolution using a Typhoon Phosphoimager (Perkin Elmer, Waltham MA). 
Relative D2 mRNA abundance was quantified by densitometric analysis 
using Densita imaging software (MBF Biosciences, Williston, VT). Hybridization 
densities were linearized and calibrated relative to the 14C-labelled standards that 
were exposed to each phosphoscreen along with tissue sections. Multiple 
measures were obtained from 4-6 sections per brain region animal. For each 
brain structure analyzed, these values were averaged to provide an individual 
mean hybridization density (µCi/g protein) per region in each subject. These 
means were used from correlations and group comparisons.  
Data Analysis 
 
Experiment 1 
Each decision-making task continued until behavior reached stability 
across a five-day period, as determined by a lack of a repeated measures 
ANOVA effect of day across those five days. Data presented represent averages 
of performances across this five-day period of stable performance.  Performance 
measures included in the data analysis were as follows: percent choice of large 
reward for each task, baseline weight prior to testing, total locomotion during 
footshock presentation in the risky decision-making task (a measure of shock 
reactivity), and latency to initiate each trial. These measures were compared to 
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each other using Pearson’s correlations. Decision-making data were also 
compared with data from the EPM, tail flick test, locomotion test, sucrose 
consumption tests, fixed and progressive ratio responding, DRL, and shock 
sensitivity to identify any relationships between individual rats’ performance 
across tasks. The relationship between behavioral measures was further 
analyzed using multiple regressions to determine if clusters of variables were 
able to predict the decision-making measures.  Because of the large number of 
variables being considered, the alpha level for all correlations and regressions 
was set at .01. This reduced the possibility of significant correlations occurring as 
a result of chance. 
Experiment 2 
 Drug treatments were analyzed using repeated measures ANOVAs (drug 
dose X punishment probability). The baseline days (days 2, 4, 6, and 8 of each 
injection schedule) were compared with each other also using repeated 
measures ANOVAs; a lack of a repeated measures effect indicated stable 
behavior. Locomotion was measured with an automated locomotion tracker 
(Coulbourn Instruments). 
Experiment 3 
Hybridization of D2 dopamine receptor cRNA in prefrontal cortex, dorsal 
striatum, and nucleus accumbens were analyzed was quantified as hybridization 
signal intensity values using scales determined by exposing C14 standards along 
with the tissue. One subject was removed from all prefrontal cortex analyses 
because of excessive tissue damage. 
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Pearson’s correlations were then run between hybridization signals and all 
behavioral scores. However, because dopaminergic mediation of complex 
behavioral tasks frequently follows a non-linear pattern that correlations would 
not detect (such as U or inverted U curve), additional analyses were performed 
on these data. First, nonlinear regressions were utilized to determine if there was 
a quadratic relationship between variables. Then, as an additional measure, rats 
were divided into three groups on the basis of behavioral characterization on 
each of the four decision-making tasks as well as impulsive action. Hybridization 
intensity was compared between these groups using one way ANOVAs. The 
other, less complex behavioral measures (motivation, anxiety, and pain 
tolerance) were only subjected to correlational analysis.  
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RESULTS 
Experiment 1 Results 
 
Decision-making Tasks 
Risky Decision-making 
  Rats achieved stable responding on sessions 16-20. Rats demonstrated a 
repeated measures effect of punishment probability (F(4,68) = 21.15, p <.001), 
indicating that rats discounted the large reward as a function of punishment 
probability (Figure 1).  
Probabilistic Discounting 
 Stable responding was achieved on sessions 16-20. Rats demonstrated a 
repeated measures effect of large reward probability (F(4,68) = 85.22, p <.001), 
indicating that rats discounted the large reward as a function of delivery 
probability (Figure 2). 
Delay Discounting 
 
 Stable responding was reached on sessions 6-10. Rats demonstrated a 
repeated measures effect of delay duration (F(4,68) = 46.49, p <.001), such that 
rats discounted the large reward as a function of its delay (Figure 3). 
Effort-based Discounting 
 
 Stable responding was reached on sessions 6-10. Rats demonstrated a 
repeated  measures   effect  of  effort   (F(4,64) = 39.58, p <.001),   such   that   rats  
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Figure 1: a.) Risky decision-making group mean. b.) Individual variability of 
risky decision-making scores. 
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Figure 2: a.) Probabilistic discounting group mean. b.) Individual variability 
of probabilistic discounting scores 
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Figure 3: a.) Delay discounting group mean. b.) Individual variability of 
delay discounting scores 
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discounted the large reward as a function of the amount of effort required (Figure 
4). 
Comparisons of Performance across Decision-making Tasks 
 
 Pearson’s r correlations between tasks are listed in Table 1. There was a 
significant positive correlation between performance on the delay discounting 
and effort-based discounting tasks (r = .60, p < .01), but there were no 
correlations between any other tasks (ps > .15).   
Motivation Assessment Tasks 
Instrumental Responding for Food Reward under Fixed and Progressive Ratios 
 Distributions and means for each fixed ratio (FR) and the progressive ratio 
schedule are displayed as Figure 5a. Lever presses on the FR1 schedule were 
not correlated with lever presses on any other FR schedule (rs < .36, n.s.). 
Performance on the FR3 schedule approached significant positive correlations 
with the FR10, FR20, and FR40 schedules (rs > .54, ps < .02), and performance  
was correlated between the FR10, FR20, and FR40 schedules (rs > .88, p 
<.001). Progressive ratio performance (as assessed by break point) was not 
correlated with lever presses on the FR1 schedule (r =.21, n.s.), was near a 
correlation with FR3 performance (r = .50, p = .03), and was correlated with 
FR10, FR20 and FR40 (rs > .76, ps < .001). 
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Figure 4: a.) Effort-based discounting group mean. b.) Individual variability 
of delay discounting scores 
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Table 1: Correlation matrix displaying relationships between cost-benefit 
decision-making tasks. There was a significant correlation between effort-
based discounting and delay discounting. No other correlations were 
observed between tasks (α= .01). 
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Figure 5: a.) Distribution of instrumental responding scores. b.) Distribution 
of sucrose consumption scores. 
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Sucrose Consumption 
 
 There was a repeated measures difference in consumption between the 
five doses of sucrose solution tested (F(4,68) = 23.2, p.s < .001) (Figure 5b). 
Individual analyses revealed that each of the solutions containing sucrose (2.5, 5, 
10, and 20% solutions) were consumed to a greater extent than the 0% sucrose 
solution (ps < .001). Further analyses demonstrated that equal amounts of 5, 10, 
and 20% solution were consumed (ps  >.26), and the amount of 5, 10, and 20% 
solutions consumed were each greater than the amount of 2.5% solution 
consumed (ps <.05). There were significant correlations within subjects for  
sucrose consumption at almost all concentrations (ps < .01), with the exceptions 
of the correlations between 5 and 10% and 2.5 and 20% sucrose (ps < .05), 
which approached significance. 
Comparison of Performance between Motivation Assessment Tasks 
 
 Correlations between motivational measures are displayed in Table 2. 
Instrumental responding on a FR1 schedule was correlated with consumption of 
a 5% sucrose solution (r = .59, p = .01), and was near-correlated with 
consumption of 2.5 (p =.04) and 20% sucrose (p = .02). Multiple regression 
analyses were performed to determine if combinations of variables displayed any 
predictive potential within the motivation variables measures. Sucrose 
consumption variables did not predict performance on any of the instrumental 
responding schedules (ps > .12), nor did the instrumental responding variables 
predict sucrose consumption at any concentration (ps > .68). 
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Table 2: Correlation matrix displaying relationships between motivation 
assessment  tasks. While several instrumental responding and sucrose 
consumption measures were correlated with each other, the only 
correlations that achieved significance between tasks were a positive 
relationship between FR1 with 5% sucrose and a negative relationship 
between FR10 with 5% sucrose (α= .01). 
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Pain Tolerance Assessment Tasks 
Shock Locomotion 
 The distribution of individual shock locomotion scores (quantified as 
average locomotor units during 1-s shock presentations on the risky decision-
making task) is displayed as Figure 6a. 
Tail Flick Test 
 There was no difference between the three measures of tail flick obtained 
(F(2,34) = 1.13, n.s); therefore, an average of each subject’s scores was used for 
subsequent analyses (Figure 6b).   
Shock Sensitivity Testing 
 All shock sensitivity scores are displayed as Figure 6c. The shock intensity 
required to elicit a motor response was strongly correlated with the intensity that 
produced a vocal response (r =.91, p < .001). 
Comparison between Measures of Pain Tolerance 
 There was a near significant correlation between shock locomotion and 
tail flick performance such that higher tail flick latencies were associated with 
increased shock locomotion (r =.58, p = .03). There were no correlations 
between other measures of pain tolerance (ps > .09) (Table 3). Additionally, a 
multiple regression using both measures of shock sensitivity to predict tail flick 
latency was not significant (p = .21).    
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Figure 6: a.) Distribution of shock locomotion scores. b.) Distribution of tail 
flick latencies. c.) Distribution of both locomotor and vocalization shock 
threshold scores. 
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Table 3: Correlation matrix displaying relationships between pain 
sensitivity measures. The only significant relationship was a positive 
correlation between shock sensitivity threshold for vocalization and shock 
sensitivity threshold for motor activity (α= .01). 
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Anxiety Assessment Tasks 
Elevated Plus Maze 
 
 The distribution of time spent in the open arms and total open arm entries 
are displayed as Figure 7a. There was a significant correlation between open 
arm entries and time spent in open arms (r = .711, p < .01). 
Locomotion Test 
 
 Horizontal activity and distance traveled in the locomotor activity 
chambers, both general measures of baseline activity, are displayed as Figure 
7b. Time spent in the center of the chamber, commonly used as a measure of 
anxiety, is displayed as Figure 7c. Horizontal activity and distance traveled were 
positively correlated with each other (r = .96, p <.001), and neither of these 
measures were correlated with time in center (rs < .22, n.s.).  
Comparison between Anxiety Measures  
 
 No correlations were observed between any measures of EPM and 
locomotion (ps > .46; Table 4). Multiple regression analyses revealed that a 
combination of all measures from the EPM did not predict any of the locomotor 
behaviors (ps > .47), nor did the combined measures of locomotion predict any 
measures from the EPM (ps > .59). 
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Figure 7: a.) Distribution of scores for total arm entries in elevated plus 
maze. b.) Distribution of scores for % time spent in open arms of elevated 
plus maze. c.) Distribution of horizontal activity, total distance, and time 
spent in the center of the open field scores.  
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Table 4: Correlation matrix displaying relationships between anxiety 
measures. While there were significant correlations between measures 
within the activity and elevated plus maze scores, there were no 
correlations between tasks (α= .01). 
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Impulsive Action Assessment Tasks 
Differential Rates of Low Responding (DRL) 
 
Performance on all DRL schedules are displayed in Figure 8. For each of 
the DRL schedules (DRL 5-s, 10-s, and 20-s), total lever presses was negatively 
correlated with ratio of correct to premature lever presses (ps < .01). 
DRL Schedule Comparison 
 
 Correlations between all DRL measures are displayed in Table 5. Total 
lever presses at DRL-5s approached a correlation with lever presses at DRL-10s 
(r = .48, p =.04). DRL-10 total lever presses was near a negative correlation with 
DRL-20s ratio (amount of reinforced responses divided by amount of premature 
responses) (r = -.52, p =.03), approached a positive correlation with DRL-30 lever 
presses (r = .49, p =.04), and achieved a significant negative correlation with 
DRL-30 ratio (r = -.63, p <.01). DRL-10 ratio approached a positive correlation 
with DRL-20 ratio (r = .47, p =.04), and DRL-20 ratio was positively correlated 
with DRL-30 ratio r = .67, p < .01).  
Relationship between Decision-making and Measures from Other Tasks 
 
 Correlations between performance in all four decision-making tasks and 
all other tasks are displayed in Table 6a-b.  
Comparisons between Decision-making and Motivation  
The only relationship between a decision-making task and a motivation 
assessment task that approached significance was a negative correlation  
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Figure 8: a.) Distribution of total lever presses for each DRL schedule. b.) 
Distribution of ratio scores for each DRL schedule. 
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Table 5: Correlation matrix displaying relationships between impulsive 
action measures. Performance on several different DRL schedules were 
positively correlated (α= .01). 
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Table 6a: Correlation matrix displaying relationships between decision-
making, motivation, and pain sensitivity. There were no significant 
correlations observed (α= .01). 
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Table 6b: Correlation matrix displaying relationships between decision-
making, anxiety, and impulsive action. There were significant negative 
correlations observed between impulsive action ratio and risk decision-
making (high risk predicts high impulsive action), and between delay 
discounting and impulsive action (high impulsive choice predicts high 
impulsive action) (α= .01).   
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between probabilistic discounting and consumption of 10% sucrose solution (r = -
.56, p = .02), meaning that rats with a preference for the large, probabilistic 
reward were less likely to consume large amounts of sucrose at this 
concentration. Multiple regression analyses were performed analyzing the ability 
of all sucrose consumption variables to predict decision-making: there were no 
significant relationships between either delay discounting, effort-based 
discounting, or risky decision-making with a composite of sucrose consumption 
performance variables (ps > .31), and a near significant predictive relationship 
between sucrose consumption and probabilistic discounting (F(4,17) = 2.72, p = 
.08). Similar analyses between the decision-making tasks and a composite of all 
instrumental responding measures revealed a near-significant relationship 
between instrumental responding (appetitive motivation) and risky decision-
making (F(6,17) =2.71, p = .07). Finally, each decision-making task was regressed 
upon composites of all motivation variables. There was a near significant 
relationship between composite motivation and risky decision-making (F(10,17) = 
3.62, p = .05), although the predictive weights of the variables were inconsistent 
and difficult to interpret (for example, FR20 was positively associated with risk, 
while FR40 was negatively associated). There were no predictive relationships 
between motivation and the other decision-making tasks (ps > .31). 
Comparisons between Decision-making and Pain Tolerance 
There were no correlations between any of the decision-making tasks and 
any of the pain assessment measures (ps > .17). The decision-making tasks 
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were each regressed upon a composite of all pain assessment measures, and 
none of these predictive relationships were significant (ps > .19). 
Comparisons between Decision-making and Anxiety 
Only one correlation approached significance between a decision-making 
task and any of the measures of anxiety: there was a negative relationship 
between effort-based discounting and percent of time spent in the open arms of 
the EPM (r = -.47, p = .05). This indicated that rats with a preference for the 
large, effort-requiring reward tended to spend a smaller percentage of time in the 
open arms (an indication of greater anxiety). Each decision-making measure was 
regressed upon a composite of all anxiety measures. None of these relationships 
were significant, although the predictive relationship between anxiety and effort-
based discounting approached significance (F(5,17) = 2.89, p = .06). 
Comparisons between Decision-making and Impulsive Action 
Several of the impulsive action assessment protocols were correlated with 
measures of decision-making. There was a significant negative correlation 
between large reward choice in the delay discounting task and total responses 
on the DRL-20 (r = -.58, p = .01), indicating that subjects that discounted the 
large reward to a greater degree also performed more inaccurate responses on 
the DRL (i.e., greater impulsive action was correlated with greater impulsive 
choice). Additionally, large reward preference on the risky decision-making task 
was negatively correlated with DRL-20 response ratio (r = -.65, p <.01), indicating 
that rats that preferred the risky option also performed a higher ratio of 
premature, impulsive responses on the DRL. There were also several near-
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significant correlations between delay discounting and DRL measures (DRL-5 
total lever presses, r = -.52, p = .03; DRL-30 total lever presses, r = -.48, p = .04; 
DRL-30 ratio, r = .53, p = .02), providing further evidence that impulsive choice is 
related to impulsive action. Finally, effort-based discounting approached a 
significant negative correlation with DRL-30 total lever presses (r = -.49, p = .04). 
 Each decision making task was then regressed upon composites of the 
different DRL test schedules. No combination of DRL variables was significantly 
predictive of probabilistic discounting or effort-based discounting (ps > .30). A 
combination of all total lever press scores on all DRL schedules was a near 
significant predictor of risky decision-making (F(4,17) = 3.30, p = .05), and the 
combination of all lever press scores was a significant predictor of delay 
discounting (F(4,17) = 4.96, p = .01) such that high impulsive action predicted high 
impulsive choice.  
Comparisons between Decision-making and Multiple Measures 
 Each decision-making task was regressed upon combinations of different 
categories of variables (for example, motivation and pain sensitivity scores were 
combined and used to predict decision-making. None of these combinations 
significantly predicted any of the four decision-making tasks (ps > .09), although 
a combination of motivation and pain measures was near-significantly predictive 
of probabilistic discounting (p = .03). 
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Experiment 2 Results 
 
Amphetamine  
 There was a main effect of drug dose (F(3,33) = 3.87, p <.05; Figure 9) such 
that rats became more risk-averse with increasing doses of amphetamine 
(although the punishment probability x drug interaction did not quite reach 
significance [F(12,132) = 1.80, p =.055]). Individual pair-wise comparisons between 
saline and amphetamine conditions showed that the 1.5 mg/kg dose caused a 
significant decrease in preference for the large reward (p < .05). In addition to its 
effects on reward choice, amphetamine also increased the number of omitted 
trials (F(3,33) = 3.92, p < .05), with omissions increasing as a function of dose (% 
completed choice trials: saline=98.66, .33 mg/kg=94.00, 1.0 mg/kg=94.34, 1.5 
mg/kg=84.00). However, the effects of amphetamine on omissions appeared to 
be separate from its effects on reward choice, as there were no correlations 
between these two variables (rs <.35, ns). There was also no difference in shock 
reactivity (locomotion during the 1 s shock presentations) across drug doses 
(F(3,21) = .12, n.s.). 
α-Flupenthixol 
 There was no effect of flupenthixol administration on choice behavior 
F(3,33) = 1.44, p =.25; Figure 10), nor was there an interaction between 
punishment probability and drug (F(12,132) = 1.02, p = .44). There was also no 
effect on trials omitted (F(3,33) = 2.26, p = .10).  
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Figure 9: Rats were tested under the influence of systemic .33, 1.0, and 1.5 
mg/kg doses of amphetamine. Amphetamine decreased preference for the 
large reward in a dose-dependent fashion, with the 1.5 mg/kg dose differing 
significantly from saline conditions (p < .05).  
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Figure 10: Rats were tested under the influence of systemic .125, .25, and .5 
mg/kg doses of the dopaminergic antagonist α-flupenthixol. Flupenthixol 
administration did not affect risky choice.  
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D1 Dopamine Receptor Manipulation 
SKF81297(D1 Agonist) 
 
 There was no effect of acute SKF81297 (D1 agonist) treatment on reward 
preference (F(3,33) = 1.73, p =.18; Figure 11a), nor was there an interaction 
between drug dose and punishment probability (F(12,132) = .83, p = .62). There 
was no effect of drug dose on trials omitted (although it did approach 
significance: F(3,33) = 2.44, p = .08). There was also a non-significant trend toward 
a drug-induced difference in locomotion (F(3,33) = 2.85, p = .053) such that the 
highest dose of SKF81297 (1.0 mg/kg) decreased baseline locomotion during the 
task compared to saline and the other two doses of SKF81297. There was no 
difference in locomotion during an average of all one second shock periods 
(F(3,21) = .44, p = .73). 
SCH23390 (D1 Antagonist) 
 
There was no effect of acute SCH23390 (D1 antagonist) on reward choice 
(F(3,33) = .03, p = .99; Figure 11b). There was no interaction between drug dose 
and punishment probability (F(12,132) = .92, p = .53). There was a significant effect 
of SCH23390 treatment on trials omitted such that the highest dose resulted in 
the highest percentage of trail omitted (F(3,33) = 5.27, p <.05; % completed choice 
trials: saline=99%, low =99.17%, mid = 99.33, high = 85%). There was also a 
significant dose-dependent difference in baseline locomotion during the task 
(F(3,33) = 3.63, p < .05) such that acute SCH23390 reduced locomotion compared  
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Figure 11: Rats were tested using drugs that target D1 dopamine receptors. 
a.) Rats were administered .1, .3, and 1.0 mg/kg skf81297. No effects on 
risky choice were observed. b.) Rats were tested under the influence of 
.005, .01, and .03 mg/kg SCH23390. Again, no effects were observed. 
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to saline. Again, there was no effect of drug treatment on locomotion during the 
shock periods (F(3,27) = 1.63, p = .21). 
D2 Dopamine Receptor Manipulation 
Bromocriptine (D2 Agonist) 
 
 Bromocriptine (D2 agonist) administration produced a dose-dependent 
decrease in preference for the risky reward (F(3,33) = 3.37, p = .03; Figure 12a). 
This increase in risk-aversion qualitatively resembled the effects of 
amphetamine, with the highest dose inducing the largest shift toward risk averse 
choice. There was also an interaction between drug dose and punishment 
probability (F(12,132) = 2.07, p = .02) such that subjects given bromocriptine 
demonstrated a more substantial shift away from the large, risky reward as the 
risk of punishment increased than subjects administered saline. There was no 
effect of bromocriptine vs. saline on baseline locomotion (F(3,33) = 2.09, p = .12), 
nor was there an effect on trials omitted (F(3,33) = 2.35, p = .09). Additionally, 
there was no effect of treatment on locomotion during the shock presentations 
(F(3,33) =.71, p = .56). 
Eticlopride (D2 Antagonist) 
 
 Eticlopride (D2 antagonist) did not affect risky choice behavior (F(3,33) = 
.86, p = .47; Figure 12b);  there was also no interaction between dose and 
punishment probability (F(12, 312) = .71, p = .74). There was no effect of eticlopride 
on trials omitted (F(3,33) = .59, p = .63), nor any effect on baseline locomotion 
(F(3,33) = 1.70, p = .19) or shock locomotion (F(3,21) = 1.70, p = .19).  
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Figure 12: Rats were tested using drugs that target D2 dopamine receptors. 
a.) Rats were administered 1, 3, and 5.0 mg/kg bromocriptine. 
Bromocriptine induced a dose-dependent attenuation of risky choice (p < 
.05). b.) Rats were tested under the influence of .01, .03, and .05 mg/kg 
eticlopride. No effects on risky decision-making were observed. 
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Combined Amphetamine and Antagonist Administration 
Amphetamine and SCH 23390 Coadministration 
 
 In order to determine whether amphetamine’s effects were acting through 
D1 or D2 receptors, amphetamine was co-administered with either a D1 or D2 
antagonist. Following combined amphetamine (5mg/kg) and SCH 23390 (D1 
antagonist; .03 mg/kg) administration, there was a significant effect of drug (F(2,22) 
= 3.65, p < .05; Figure 13) such that both amphetamine and amphetamine 
coadministered with SCH23390 decreased preference for the risky reward 
relative to saline, There was also a significant drug X punishment probability 
interaction F(4,44) = 3.31, p < .01). Individual comparisons revealed that there was 
a significant difference between saline treatment and amphetamine + SCH co-
administration (F(2,22) = 5.13, p < .05) such that the combined drug treatment 
attenuated risky choice, and a near-significant difference between amphetamine 
treatment and saline treatment (F(2,22) = 4.40 p = .06). There was no difference  
between amphetamine treatment and amphetamine and SCH co-administration 
(p = .60), indicating that the effects of amphetamine on risky choice persist even 
in the absence of D1 dopamine receptor activation. There was no difference in 
trials omitted between groups (F(2,22) = .71 p = .51). There was an effect of drug 
treatment on baseline locomotion (F(2,22) = 6.88 p < .01) such that both 
amphetamine and amphetamine + SCH co-administration caused more 
locomotor activity than saline treatment.  
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Figure 13: Rats were tested under the influence of either saline, 
amphetamine alone (5 mg/kg), or amphetamine (5 mg/kg) coadministered 
with the D1 antagonist SCH 23390 (.03 mg/kg). Amphetamine administered 
with SCH 23390 attenuated risky choice in the same fashion as 
amphetamine (p < .05), indicating that D1 receptor activation is not 
necessary for amphetamine’s effects on risky choice. 
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Amphetamine and Eticlopride Coadministration 
 
There was an effect of drug schedule on reward preference (F(2,22) = 4.22, 
p < .05; Figure 14) and an interaction between drug and block (F(8,88) = 3.94, p < 
.01). This interaction indicated that amphetamine decreased risky choice 
behavior in comparison to saline treatment, but amphetamine co-administered 
with eticlopride did not affect choice behavior (i.e., the D2 antagonist blocked the 
effects of amphetamine). Further statistical evidence for this effect was obtained 
by performing ANOVA comparing individual treatments; rats given saline and 
amphetamine showed significantly more risk aversion than rats given only saline 
(F(1,11) = 5.89, p <.05), while, importantly, there was no significant difference 
between rats given eticlopride + amphetamine and those given saline only (F(1,11) 
= 1.01, p =.34). Additionally, there was a near significant difference between 
performance under acute amphetamine and a combination of amphetamine and 
eticlopride (F(1,11) = 4.16,  p =.066) such that rats given amphetamine 
demonstrated a larger shift toward risk-averse choice than rats given the 
combination of drugs. There was no effect of drug administration on trials omitted  
 (F(2,22) =.60, p =.56). Interestingly, there was an effect of drug on overall 
locomotion during testing (F(2,22) =19.19, p <.01) such that administration of  
amphetamine or amphetamine with eticlopride both increased locomotion relative 
to saline (i.e. –eticlopride did not block the locomotor stimulant effect of 
ampmethamine). There was no effect of drug treatment on average locomotion 
during the shock periods (F(2,6) =.63, p =.55). 
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Figure 14: Rats were tested under the influence of either saline, 
amphetamine alone (5 mg/kg), or amphetamine (5 mg/kg) coadministered 
with the D2 antagonist eticlopride (.05 mg/kg). Amphetamine administered 
independently attenuated risky choice (p < .05), but amphetamine 
coadministered with eticlopride did not affect risky decision-making. This 
indicated that D2 receptor activation is necessary for amphetamine’s 
effects on risky choice. 
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Experiment 3 Results 
 
Because the D2 rather than D1 dopamine receptor had been 
demonstrated to mediate risky decision-making behavior in Experiment 2, D2 
receptor cRNA was chosen for this experiment. Figure 15 shows levels of D2 
dopamine cRNA hybridization in prefrontal cortical-striatal circuitry from 
behaviorally characterized animals (orbitofrontal cortex [OFC], medial prefrontal 
cortex [mPFC], dorsal striatum [DS], and nucleus accumbens [NAcc]). Sample 
hemisections, as well as the regions analyzed, are displayed as Figure 16. 
The Relationship between D2 Dopamine Receptor cRNA Hybridization and 
Risky Decision-making Behavior 
 There were no significant linear correlations between risky decision-
making performance and D2 cRNA hybridization in any of the brain regions 
analyzed (ps > .17). However, regionally-specific monoamine transmission often 
mediates behavior in a non-linear fashion, manifested as a U- or inverted U-
shaped curve (Cai & Arnsten 1997; Robbins 2005), which would be undetectable 
utilizing linear correlations. To address this possibility, nonlinear curve estimation 
analyses were also performed, specifically to determine if the relationship 
between data sets was best reflected by a quadratic function. Additionally, to 
further confirm the relationship between risk and D2 cRNA hybridization, rats 
were split evenly into three groups based on task performance: risk-averse, 
moderate risk, or risk-taking (Figure 17). Region-specific D2 cRNA hybridization 
was then compared between these groups using one way ANOVAs. 
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Figure 15: a.) Distribution of D2 mRNA hybridization signals in prefrontal 
cortical areas. OFC = orbitofrontal cortex, mPFC = medial prefrontal cortex. 
b.) Distribution of D2 mRNA hybridization signals in striatum. DS = dorsal 
striatum, NAcc = nucleus accumbens. 
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Figure 16: a.) Sample hybridized hemisection containing mPFC (prefrontal 
region outlined along the midline) and OFC (located dorsal to the olfactory 
bulb and lateral to mPFC) regions. b.) Sample hybridized hemisection 
containing DS (ventral to corpus callosum) and NAcc (surrounding the 
anterior portion of anterior commisure) regions. 
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Figure 17: Rats were divided into three evenly sized groups based on risky 
decision-making performance: risk-averse, moderate, and risk-taking. 
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Prefrontal Cortex 
 
There was a significant quadratic relationship between OFC hybridization and 
risk that resembled a U curve (F(2,14) = 4.46, p  < .05; Figure 18a). There was also 
an effect of risk level on D2 cRNA hybridization in OFC (F(2,14) = 7.60, p < .05) 
such that the risk-averse and risk-taking groups both displayed a greater 
hybridization signal than the moderate risk group (Figure 18b). These 
relationships were confirmed statistically by LSD post hoc analyses (ps < .01). 
Interestingly, a contrasting nonlinear function was found in mPFC, with the 
relationship between mPFC and risk resembling an inverted U curve (F(2,14) 
=5.60, p <.05; Figure 18c). There was also an effect of risk level on hybridization 
in mPFC (F(2,14) = 4.32, p < .05; such that the moderate risk group demonstrated 
a higher hybridization signal than the risk-averse or risk-taking groups (Figure 
18d). LSD post hoc analyses revealed that the moderate risk group had higher 
levels of cRNA hybridization in mPFC than the risk-taking group (p < .05), and 
there were no other differences between groups (ps > .18). 
Striatum 
 
There was a significant nonlinear relationship between D2 hybridization in 
DS and risk that resembled a modified U curve (F(2,15) = 7.26, p  < .01; Figure 
19a).  An ANOVA revealed a significant effect such that the risk averse group 
exhibited a higher hybridization signal than the moderate risk and risk-taking 
groups, and the risk-taking group showed a higher signal than the moderate risk 
group (F(2,15) = 6.52, p < .01; Figure 19b). LSD post hoc comparisons confirmed 
that hybridization was significantly greater in the risk-averse group than in 
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Figure 18: a.) There was a quadratic relationship between OFC D2 mRNA 
and risky decision-making (p < .05). b.) D2 mRNA hybridization in OFC was 
greater in the risk averse and risk taking groups than in the moderate risk 
group (p < .05). c.) There was an inverted U-shaped quadratic relationship 
between D2 mRNA in mPFC and risky choice (p < .05). d.) The moderate 
risk group displayed greater D2 mRNA hybridization in mPFC than the risk-
taking or risk-averse groups (p < .05). 
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Figure 19: a.) There was a quadratic relationship between DS D2 mRNA and 
risky decision-making (p < .01). b.) D2 mRNA hybridization in DS was 
greater in the risk averse than both the risk taking and moderate risk 
groups (p < .05). c.) There was no relationship between D2 mRNA in NAcc 
and risky choice. d.) There was no difference in NAcc D2 hybridization 
between groups. 
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both the moderate risk and the risk-taking groups  (p < .01), while a comparison 
showed that the moderate risk and risk-taking groups were not significantly 
different (ps  =  .21). There was neither a significant quadratic relationship 
between NAcc cRNA hybridization and risky decision-making (p = .50), nor any 
difference between risk levels in D2 cRNA hybridization in NAcc (F (2,15) = 2.19, p 
= .15) (Figure 19 c-d).  
The Relationship between D2 Dopamine Receptor cRNA Hybridization and 
Other Cost-benefit Decision-making Tasks 
Probabilistic Discounting and Prefrontal Cortex 
 
Performance on the probabilistic discounting task approached a negative 
linear correlation with cRNA hybridization in OFC (r = 1.52, p =.03; Figure 20a), 
such that preference for the large, probabilistic risky reward was associated with 
a lower abundance of D2 mRNA. This relationship was analyzed further by 
dividing subjects into three even groups based on probabilistic discounting 
performance (high prob, mid prob, low prob, with the high prob group 
corresponding with the highest level of probabilistic risk), then performing an 
ANOVA comparing D2 hybridization between probability groups, with the low 
prob group displaying a higher level of D2 cRNA hybridization in OFC than both 
the mid prob and high prob groups (F (2,15)=8.74, p <.01, Figure 20b). These 
group differences were confirmed with LSD post hoc analyses (ps < .01).  
Additionally, D2 cRNA hybridization in mPFC reached a near-significant 
positive correlation with probabilistic discounting (r = .48, p = .053; Figure 20c) 
indicating the trend that rats with preference for the large, probabilistic reward  
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Figure 20: a.) There was a linear negative correlation between OFC D2 
mRNA and probabilistic discounting (p < .05). b.) D2 mRNA hybridization in 
OFC was greater in the risk averse than both the risk taking and moderate 
risk groups (p < .01). c.) There was no significant relationship between D2 
mRNA in mPFC and probabilistic discounting. d.) There was no difference 
in mPFC D2 hybridization between groups. 
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were more likely to display higher levels of hybridization in mPFC. An ANOVA 
comparing D2 cRNA hybridization between groups based on probabilistic 
discounting performance in mPFC was also near significant (F(2,15) = 3.36, p = 
.06; Figure 20d).  
Probabilistic Discounting and Striatum 
 
There were no significant linear or nonlinear correlations or ANOVAs 
associating probabilistic discounting with D2 hybridization in either DS or NAcc 
(ps > .17). There were also no effects of group on hybridization in either region 
(ps > .54; Figure 21). 
Delay Discounting and Prefrontal Cortex 
 
 Delay discounting performance was not significantly linearly correlated 
with D2 cRNA hybridization in either OFC or mPFC (ps  > .07). There was no 
significant non-linear relationship between OFC and choice of the delayed 
reward (p = .19), nor was there any no effect of group on cRNA hybridization in 
OFC, although it approached significance (p = .06; Figure 22a-b). Non-linear 
curve estimation analysis revealed a significant quadratic relationship between 
D2 cRNA hybridization in mPFC and delay discounting manifested as a U curve 
(F(2,14) = 10.78, p < .01; Figure 22c). Rats were then broken up into three groups 
based on delay discounting performance (high impulsivity, mid impulsivity, and 
low impulsivity, with impulsivity inversely related to large reward preference), and 
D2 expression was compared between these groups. Within mPFC, both the 
high impulsivity and low impulsivity groups displayed higher hybridization than 
the mid impulsivity group (F(2,15) = 3.80, p < .05; Figure 22d). LSD post hoc tests 
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Figure 21: a.) There was no relationship between DS D2 mRNA 
hybridization and probabilistic discounting. b.) There was no difference in 
D2 mRNA hybridization in DS between groups. c.) There was no significant 
relationship between D2 mRNA in NAcc and probabilistic discounting. d.) 
There was no difference in NAcc D2 hybridization between groups. 
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Figure 22: a.) There was no significant relationship between OFC D2 mRNA 
hybridization and delay discounting. b.) There was no difference in D2 
mRNA hybridization in OFC between groups. c.) There was a quadratic 
relationship between D2 mRNA hybridization in mPFC and delay 
discounting (p < .01). d.) The high and low impulsivity groups both 
exhibited greater D2 mRNA abundance in mPFC than the mid group. 
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revealed that the high impulsive rats had significantly more hybridization in 
mPFC than mid impulsive rats (p < .05), that there was a near significant 
difference between low impulsive and mid impulsive rats (p = .07) and that there 
was no difference between high and low impulsive rats (p = .37).  
Delay Discounting and Striatum 
 
There were no significant linear correlations or nonlinear curve estimation 
analyses between DS or NAcc and delay discounting performance. There were 
also no effects of impulsivity group on cRNA hybridization in either region, 
although DS approached significance (p =.07; Figure 23). 
Effort-based Discounting and Prefrontal Cortex  
 
 There were no significant linear correlations between effort-based 
discounting and D2 cRNA hybridization in OFC or mPFC (ps  > .29), nor were 
there any significant relationships based on quadratic curve-fit analysis (ps  > 
.31). Finally, there were no effects of effort group on hybridization in OFC or 
mPFC (ps > .35; Figure 24).  
 Effort-based Discounting and Striatum 
 
 There were no significant correlations, non linear curves, or group 
comparisons between effort and cRNA hybridization in DS or NAcc (ps > .47; 
Figure 25). 
The Relationship between D2 cRNA Hybridization and Impulsive Action 
 There were no significant correlations between cRNA hybridization and 
impulsive action as assessed in any of the DRL protocols (ps > .20). As with the  
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Figure 23: a.) There was no relationship between DS D2 mRNA 
hybridization and delay discounting. b.) There was no difference in D2 
mRNA hybridization in DS between groups. c.) There was no relationship 
between D2 mRNA in NAcc and delay discounting. d.) There was no 
difference in NAcc D2 hybridization between groups. 
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Figure 24: a.) There was no relationship between OFC D2 mRNA 
hybridization and effort-based discounting. b.) There was no difference in 
D2 mRNA hybridization in OFC between groups. c.) There was no 
relationship between D2 mRNA in mPFC and effort-based discounting. d.) 
There was no difference in mPFC D2 hybridization between groups. 
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Figure 25: a.) There was no relationship between DS D2 mRNA 
hybridization and effort-based discounting. b.) There was no difference in 
D2 mRNA hybridization in DS between groups. c.) There was no 
relationship between D2 mRNA in NAcc and effort-based discounting. d.) 
There was no difference in NAcc D2 hybridization between groups. 
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decision-making tasks, it was expected that the relationships between factors 
may be non-linear; therefore, curve estimation analysis was utilized to test for the 
presence of a quadratic relationship between variables. There was a significant 
quadratic relationship between DRL-20 performance and hybridization in mPFC 
that resembled a modified inverted U curve (F(2,14) = 4.13, p < .05; Figure 26). 
There were no other significant quadratic relationships between any other brain 
regions and any other measures of impulsive action (ps > .23). 
As earlier, rats were split evenly into three groups based on task 
performance and ANOVAs were performed comparing hybridization between 
groups. There was a significant difference between groups in NAcc hybridization 
signal such that rats in the high impulsive action group displayed reduced cRNA 
hybridization compared to rats with either mid- or low- impulsive action (F(2,15) = 
5.07, p < .05; Figure 27). Post hoc tests demonstrated that there was a 
significant difference between high and mid impulsive groups (p < .01), a near 
significant difference between high and low impulsive groups (p = .08), and no 
difference between high and mid impulsive groups (p = .21). There were no other 
differences in cRNA hybridization between groups for the other brain regions (ps 
> .19).    
The Relationship between D2 cRNA Hybridization and Other Behavioral 
Tasks 
Motivation 
There were significant negative linear correlations between mPFC D2  
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Figure 26: a.) There was no relationship between OFC D2 mRNA 
hybridization and impulsive action. b.) There was no difference in D2 mRNA 
hybridization in OFC between groups. c.) There was a significant inverted 
U-shaped relationship between D2 mRNA in mPFC and impulsive action (p 
< .05). d.) There was no difference in mPFC D2 hybridization between 
groups. 
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Figure 27: a.) There was no relationship between DS D2 mRNA 
hybridization and impulsive action. b.) There was no difference in D2 mRNA 
hybridization in DS between groups. c.) There was a significant nonlinear 
relationship between D2 mRNA in NAcc and impulsive action (p < .05). d.) 
There was a difference in NAcc D2 hybridization between groups such that 
the high impulsive action group displayed less D2 mRNA hybridization 
than the mid impulsive action group (p < .01). 
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cRNA hybridization and both 2.5 and 20% sucrose consumption (rs > .64, ps < 
.01), and there was a near-significant negative correlation between 10% sucrose 
consumption and mPFC hybridization (r = -.54, p = .03). The data indicate that 
D2 mRNA in mPFC is associated with lower levels of consummatory motivation 
for sucrose. There were no significant correlations between hybridization in any 
other region and any measures of motivation (ps > .07).  
Pain Tolerance 
 
 There were near significant correlations between OFC hybridization and 
both motor and vocalization shock thresholds (rs > .57, ps > .02), indicating that 
higher D2 mRNA levels in OFC are associated with a higher pain tolerance in 
response to shock. In contrast, there was a near significant negative correlation 
between tail flick latency and OFC D2 hybridization (r = -.55, p = .02), suggesting 
that higher D2 levels in OFC may also be associated with reduced tolerance to 
pain as assessed by the tail flick test. A similar near-significant negative 
correlation was found between tail flick latency and dorsal striatum D2 
hybridization (r = -.49, p = .04). There were no other significant correlations 
between measures of pain tolerance and D2 hybridization (ps > .11). 
Anxiety 
 
 There were significant negative correlations between D2 hybridization in 
mPFC and both horizontal activity and total locomotion in the open field test (rs > 
-.61, ps < .01), indicating that increased D2 in mPFC is associated with  
decreased general locomotor activity. There was also a near significant positive 
correlation between mPFC hybridization and time spent in the center of the open 
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field chamber (r = .55, p = .02), suggesting that higher mPFC D2 hybridization is 
associated with lower levels of general anxiety.   
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DISCUSSION 
 
Experiment 1: The Relationship between Risky Decision-making and Other 
Behavioral Measures 
 Rats were characterized in risky decision-making, then three other cost-
benefit decision-making tasks: probabilistic, delay, and effort-based discounting. 
Importantly, there were no correlations between risky decision-making and these 
other tasks. Rats demonstrated the ability to shift reward preference in 
accordance with changes in discounting factors, resulting in distinct discounting 
curves and distributions of individual performance across all tasks. The only 
significant relationship among performance on these tasks observed was 
between delay discounting and effort-based discounting, such that rats with a 
high tolerance for delays (lower levels of impulsive choice) were also willing to 
exert more effort for large rewards. The lack of a relationship between 
probabilistic discounting and delay discounting was as expected, as this non-
relationship had been observed previously by our lab (Simon et al., 2009), and 
there is considerable evidence suggesting that delay and probabilistic 
discounting utilize distinct neural pathways (Cardinal 2006; Green et al. 1999; 
Kheramin et al. 2003; Weber & Huettel 2008). In contrast with previous data, 
however, there was no relationship between probabilistic discounting and risky 
decision-making (Simon et al., 2009), although it is important to note that the 
variance observed in probabilistic discounting was considerably less here than in 
Simon et al., which may have contributed to the lack of an observed correlation 
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(especially when considering the high degree of variance observed in the risky 
decision-making task).  
 There were no significant correlations between performance in any 
decision-making task and behavioral measures of motivation, pain tolerance, or 
anxiety. The absence of a relationship between pain tolerance and the novel 
risky decision-making task is of particular importance because this task 
incorporates an aspect of physical punishment (footshock) that has heretofore 
not been integrated into any rodent cost-benefit decision-making tasks. Thus, it 
was possible that the physical response to painful stimuli may be the principal 
factor mediating choice behavior during this task (rather than risk). However, the 
complete lack of relationship between any of multiple measures of pain tolerance 
and risky decision-making indicated that choice was likely not mediated solely by 
sensitivity to pain, but instead by a separate reward discounting process that 
reflected willingness to risk punishment. 
 The lack of a correlation between any measures of motivation and 
decision-making is somewhat inconsistent with a recent study by Rivalan et al. 
(2009). In this study, rats that demonstrated maladaptive decision-making on a 
rat model of the Iowa Gambling Task also showed greater levels of appetitive 
motivation as assessed by a progressive ratio instrumental task. In the current 
study, there were no relationships between any forms of cost-benefit decision-
making and progressive ratio performance. This is likely a result of subtle task 
differences: in Rivalan et al., the decision-making task included specific 
alternatives that were optimal in comparison to the other choices (based on total 
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food received), which classifies this task as a measure of ability to assess 
outcomes within working memory. This differs from the majority of the cost-
benefit decision-making tasks outlined in this study, which instead offered 
choices between two options that were both associated with varying costs and 
benefits (without a clear “correct” option). Therefore, the differences between the 
constructs being measured by these distinct tasks offer an explanation for the 
differences in observed correlations. 
  Several relationships were observed between measures of impulsive 
action and cost-benefit decision-making. There was a relationship between delay 
discounting and impulsive action as assessed by the DRL task such that rats with 
high levels of impulsive choice also demonstrated high impulsive action. These 
data provide evidence that different aspects of impulsivity may reflect a unitary 
construct. Indeed, increases in both impulsive action and impulsive choice have 
been found to result from extended psychostimulant access (Fletcher et al. 2007; 
Peterson et al. 2003; Roesch et al. 2007b; Simon et al. 2007), and high levels of 
both of these traits predict several aspects of drug self-administration (Anker et 
al. 2009; Belin et al. 2008; Dalley et al. 2007; Perry et al. 2005; Perry et al. 2008). 
However, there is also considerable evidence from pharmacological and lesion 
studies that these different aspects of impulsivity are mediated by distinct 
mechanisms (Pattij & Vanderschuren 2008; Voon et al. 2010; Winstanley et al. 
2004a). The discrepancy between the results of this experiment and these data 
may be a result of task differences, as this study utilized the DRL to measure 
impulsive action while the others used the 5-choice serial reaction time task. 
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While the DRL has been frequently used to measure impulsive action (Evenden 
& Ryan 1996; Sokolowski & Salamone 1994; Uslaner & Robinson 2006), it is 
also possible that this task is reflective of time assessment (Orduña et al. 2009). 
This could potentially explain the relationship found between DRL and delay 
discounting, as rats with abnormal timing ability may also demonstrate an 
overestimation of delays, leading to an increase in the discounting of delayed 
rewards. 
 There was also a correlation between the risky decision-making task and 
DRL performance such that rats with a preference for the risky reward 
demonstrated higher levels of impulsive action. One potential explanation for this 
result is that impulsive action and risky decision-making are governed by similar 
brain pathways and pharmacological substrates, an assumption that will require 
further delineation of the biological circuitry underlying risky decision-making 
utilizing lesion studies to confirm. Another possibility is that choice of the risky 
reward is a direct result of a highly impulsive behavioral phenotype. The risky 
reward is not accompanied by punishment during the opening trials of the risky 
decision-making task, then subsequently becomes associated with increased risk 
of punishment as the task progresses. Impulsive action can be defined as an 
inability to withhold a prepotent response; rats that continue to select the risky 
reward may be responding in this fashion because of an inability to withhold the 
previously “safe” choice of the large reward even after it becomes a “risky” 
option. However, there is some evidence to the contrary, as impulsive action 
does not predict choice of the large reward during the probabilistic discounting 
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task. Had cost-benefit decision-making response patterns in general been 
governed by prepotent responding in impulsive rats, then rats characterized as 
impulsive on the DRL task would have been expected to continue to select the 
large, initially advantageous reward throughout this task (even when selection 
produces 0% reinforcement during the final block of each session). 
 In summary, risky decision-making in rats cannot be predicted by general 
behavioral processes such as motivation, anxiety, and pain tolerance. Therefore, 
at least to some degree, the integration of rewards with risk of physical 
punishment in order to guide choice behavior can be measured as a distinct 
behavioral construct. Additionally, the discounting of rewards via probabilistic 
punishment appears to be regulated differently from the discounting of rewards 
due to delay, probability of reward omission, or effort required, as reward 
preference shifted differently according to the discounting factor being utilized, 
and there were no correlations between risky decision-making and the other 
three tasks. Risky choice was correlated with impulsive action, suggesting that 
these processes may be mechanistically similar, or that they may interact in 
some fashion (i.e., impulsive rats may be more likely to select an option that had 
been associated with reward earlier without fully considering the degree of risk 
involved).         
Experiment 2: The Effects of Systemic Dopaminergic Manipulation on Risky 
Decision-making 
 
Systemic amphetamine administration produced a dose-dependent 
decrease in risk-taking during the risky decision-making task, shifting rats' 
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preference toward the 'safe' reward. This effect (which resulted in less overall 
food availability) was likely not an artifact of amphetamine induced suppression 
of food intake (Wellman et al. 2009), because previous work in our lab 
demonstrated that neither 1- nor 24-h periods of free feeding before testing had 
an effect on reward choice, although 24-h free feeding did increase the number 
of trials omitted (an effect that was also observed under amphetamine) (Simon et 
al. 2009). Another possibility is that the increased preference for the small, safe 
reward induced by amphetamine was a result of increased pain sensitivity to 
footshock. This explanation seems unlikely for three reasons: first, amphetamine 
has been characterized as an analgesic agent  (Connor et al. 2000; Drago et al. 
1984). If pain sensitivity were indeed the critical mediator of reward selection in 
this task, rats given amphetamine would be expected to find the shock less 
aversive and shift their preference toward the large reward as a result of a higher 
pain threshold. Second, amphetamine did not alter reactivity (as assessed by 
locomotion) during the footshock, which can be used as a behavioral marker for 
pain/shock sensitivity (Chhatwal et al. 2005). Third, data from Experiment 1 
showed that reward choice was not associated with various measures of pain 
tolerance, indicating that the level of pain induced by the footshock is likely not 
the critical factor mediating reward choice.     
While amphetamine elicits an increase in synaptic dopamine, serotonin, 
and norepinephrine, our experiments focused on the dopaminergic system, as 
amphetamine induces a larger increase in dopamine activity than other 
neurotransmitter systems (Azzaro & Rutledge 1973; White & Kalivas 1998) (to be 
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discussed further below). Amphetamine does not act on specific dopaminergic 
receptor subtypes, but instead causes a general increase in synaptic dopamine, 
which in turn acts on all dopamine receptors in a nondiscriminatory fashion. To 
address which receptor subtypes may specifically mediate risky choice, the 
effects of dopaminergic agents specific to either D1 or D2 dopamine receptors on 
risk were observed. Neither SKF81297, a D1 dopamine receptor agonist, nor 
SCH23390, a D1 dopamine receptor antagonist, influenced risky decision-
making behavior. Furthermore, co-administration of SCH 23390 with 
amphetamine was not sufficient to block the amphetamine-induced attenuation in 
preference for the risky reward. Therefore, it seems that D1 dopamine receptors 
do not directly mediate risky decision-making behavior in rats. 
In contrast, bromocriptine, a D2 receptor agonist, caused a decrease in 
risky choice during the risky decision-making task. This effect was dose 
dependent, and qualitatively resembled the effects of acute amphetamine on 
risky decision-making behavior.  Eticlopride, a D2 antagonist, did not affect risky 
decision-making behavior. Importantly, however, coadministering eticlopride with 
amphetamine blocked amphetamine’s effects on risky choice without blocking 
amphetamine’s general locomotor enhancing effects. These data provide 
evidence that D2 dopamine receptors are necessary for amphetamine to exert an 
influence on risky choice, and sufficient to alter risky choice independently from 
D1 activation. 
It is difficult to discern the mechanism of action of drugs that target the D2 
dopamine receptor, as two distinct manifestations of D2 receptors have been 
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identified. One of these acts as a standard post-synaptic receptor, while the other 
is located presynaptically and functions as an autoreceptor that inhibits dopamine 
release from the terminal (De Mei et al. 2009). Despite the functional differences 
between these receptor types, they possess similar pharmacodynamic 
properties, and thus would have similar affinities for D2 agonists or antagonists 
(Emilien et al. 1999). Therefore, a D2 agonist exerts opposing effects on post 
synaptic neurons, simultaneously binding to autoreceptors (thereby reducing 
available dopamine in the synapse) and directly binding to postsynaptic 
receptors. Conversely, a D2 antagonist would increase synaptic dopamine 
through blockade of the autoreceptors, while also blocking postsynaptic 
receptors. One method that may be utilized to delineate the effects of pre- and 
post-synaptic D2 receptors on risky choice would be to utilize genetic knockout 
subjects, as knockouts specific to either D2 isoform have been developed 
(Centonze et al. 2004; Lindgren et al. 2003).    
   The shift toward risk aversion induced by amphetamine and 
bromocriptine seems somewhat counterintuitive, as structures such as ventral 
tegmental area and NAcc that are profoundly impacted by dopaminergic drugs 
have frequently been implicated in aspects of reward-seeking/motivation 
(Berridge 2007; Everitt & Robbins 2005; Kelley et al. 2005; Salamone et al. 1994; 
Wise 2009), and intracranial infusions of amphetamine into NAcc enhance 
reward motivation (Phillips et al. 2003). However, the same areas implicated in 
reward also appear to be involved with emotional reactions to aversive stimuli 
(Carlezon & Thomas 2009; Liu et al. 2008; Setlow et al. 2003). Thus, it is 
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possible that amphetamine-induced enhancements in dopamine transmission 
increase the ability of aversive stimuli to control behavior (rather than solely 
enhancing the influence of rewarding stimuli), which could explain the 
amphetamine-induced shift in reward choice away from the large, risky reward. 
This explanation is consistent with previous findings showing that acute 
amphetamine administration at doses similar to those used here increased the 
degree to which rats avoided making a response that produced an aversive 
conditioned stimulus previously associated with footshock (i.e., amphetamine 
increased control over responding by the aversive conditioned stimulus (Killcross 
et al. 1997)).  
Interestingly, humans demonstrate “paranoid” patterns of behavior 
following amphetamine exposure during which they report accentuated sensitivity 
to aversive events, memories, and cues (Dawe et al. 2009; Ellinwood & Cohen 
1971; Moutoussis et al. 2007). This hypersensitivity produces avoidant and 
overly cautious behavior, which may be analogous to the increase in risk-averse 
choice seen in amphetamine-exposed rats performing the risky decision-making 
task. Thus, this task may offer a potential animal model (albeit solely based on a 
behavioral phenotype) of amphetamine-induced “paranoid” behavior. 
The data obtained in this experiment are consistent with Zeeb et al. 
(2009), in which the novel Rat Gambling Task was used to measure risky choice 
in rats during which the risky option was accompanied by a possibility of a “time 
out” during which no food was available (resulting in less overall food availability 
over the course of the session). The multiple options presented during this task 
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included an excessively risky option with large rewards and punishment, a safe 
option with a small magnitude of both reward and punishment, and a moderately 
risky option that ultimately produced the largest amount of net reward throughout 
the session (which rats typically preferred upon acquisition of the task). 
Interestingly, acute amphetamine caused an increase in selection of the safest 
option and a reduced selection of the moderate-risk option. Therefore, 
amphetamine induced an increase in risk aversion that resulted in a sub-optimal 
amount of available reward. Thus, risk of physical punishment and risk of “time-
outs” during which rewards and active participation in the task are unavailable 
seem to both be attenuated by amphetamine. 
The attenuation in risk-taking induced by amphetamine and bromocriptine 
differed from effects observed on a probabilistic decision-making task, which 
measured risk of reward omission rather than risk of punishment. St. Onge and 
Floresco (2009) reported that both amphetamine and bromocriptine increased 
risky choice in a probabilistic discounting task, which is contrary to the decrease 
in risky choice found here. This dissociation was likely a result of the difference in 
discounting factors associated with the large reward between these tasks: 
dopamine neurotransmission appears to enhance the salience of a punishing 
factor (footshock) (Killcross et al. 1997, Simon et al. 2009), thereby biasing 
behavior away from the large reward in the risky decision-making task because 
of the enhanced salience of the threat of punishment. On the other hand, in the 
probabilistic discounting task, dopamine neurotransmission may bias behavior 
toward the large reward because the discounting factor is not physical 
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punishment, but is instead probability of omission. Therefore, rats would be more 
likely to “gamble” due to the enhanced salience of the food reward and the 
relatively smaller salience of the food omission. Another possibility is that the 
integration of distinct discounting factors (reward omission vs. punishment) with 
rewards may utilize separate neural and pharmacological mechanisms, with 
these distinct systems responding differently to augmented dopamine activity. 
Also contradictory to previous data were the lack of effects of the D2 dopamine 
receptor antagonist eticlopride on risky decision-making. D2 antagonists had 
previously been shown to decrease risky choice in probabilistic discounting (St. 
Onge et al. 2009) and the Rat Gambling Task (Zeeb et al. 2009). Again, this 
discrepancy can likely be attributed to differences between tasks. 
An important factor to consider is that the effects of amphetamine may be 
partially mediated by neurotransmitters other than dopamine, as amphetamine 
also enhances serotonin transmission (Azzaro & Rutledge 1973; Holmes & 
Rutledge 1976). Serotonin has been found to mediate risky behavior (Juhasz et 
al. in press) as well as other forms of cost-benefit decision-making (Pattij & 
Vanderschuren 2008; Winstanley et al., 2005), and therefore could be 
responsible for the amphetamine induced attenuation of risky decision-making. 
However, this is improbable for two reasons: first, administration of the D2 
agonist bromocriptine, which has no direct effect on serotonin transmission, was 
sufficient to replicate the behavioral effects of amphetamine on risky choice (See 
Figures 9 and 12). Second, in a previous study, the effects of acute cocaine 
exposure, which has much greater affinity for the serotonin transporter than 
85 
 
amphetamine (White & Kalivas 1998), did not induce an attenuation of risk, but 
instead seemed to produce an impairment in probability recognition (Simon et al. 
2009) . Therefore, it is unlikely that amphetamine’s effects on risky choice are 
solely a result of enhanced serotonin availability (although it seems likely that 
serotonin is involved with risky decision-making behavior in some fashion, and 
this issue merits further exploration). Norepinephrine availability in the synapse is 
also enhanced by amphetamine, and more research is necessary to clarify the 
specific role of this neurotransmitter in rat models of risky choice.   
 In conclusion, amphetamine causes a dose-dependent decrease in risky 
choice behavior. This effect can be duplicated using the specific D2 receptor 
agonist bromocriptine, and can also be blocked by coadministering the D2 
antagonist eticlopride with amphetamine. In contrast, the D1 agonist SKF81297 
is not sufficient to produce this effect, and co-administration of the D1 antagonist 
SCH23390 with amphetamine does not block the effect. Therefore, it can be 
surmised that D2 receptors play a critical role in the mediation of risky choice 
behavior, and offer a potential therapeutic target for psychopathologies 
characterized by excessive risk-taking. 
Experiment 3: The Relationship between Dopamine Receptor mRNA and Risky 
Decision-making 
Prefrontal Cortex Dopaminergic Mediation of Risky Decision-making 
The results obtained in Experiment 2 suggested that D2 dopamine 
receptors are particularly involved in risky decision-making behavior. In 
Experiment 3, the relationship between baseline D2 receptor expression in 
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various brain regions and risky decision-making was assessed. A nonlinear 
relationship was uncovered between risky choice and D2 receptor expression in 
OFC, a region implicated in representation of both reward and punishment as 
well as the integration of information to guide complex decision-making 
processes (McCabe et al. ; Morrison & Salzman 2009; Rolls 2004; Schoenbaum 
et al. 2006; Schultz 2007). Rats that demonstrated either a profound preference 
for the risky reward or an aversion toward risky choice both displayed higher 
levels of D2 expression in OFC than rats that displayed moderate levels of risk-
taking. Therefore, higher levels of D2 receptor expression in OFC seem to be 
related to “behavioral extremes” such that rats exhibit a strong preference (or 
aversion) toward a specific option and rarely shift reward preference despite 
changes in contingencies, whereas rats with lower levels of D2 expression were 
better able to modify their behavior according to the changing response-outcome 
contingencies.      
 Curiously, D2 expression in mPFC adheres to an opposite trend, with the 
moderately risky behavioral phenotype being associated with a higher level of D2 
mRNA than both the risk-taking and risk-averse phenotype. This inverted U-
shaped pattern is in stark contrast to the U-shaped pattern of results in OFC, and 
suggests that the two structures mediate risky choice in a dissociable fashion. It 
is conceivable that risky choice is a function of the relationship between 
structures, as these structures interact through reciprocal connections 
(Moghaddam & Homayoun 2007). OFC and mPFC form a circuit involved in the 
prediction and evaluation of the economic value of outcomes (OFC) and the 
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execution of the appropriate action (mPFC), and opposing patterns of plasticity 
between these structures have been observed during encoding of appetitive 
information (Moghaddam & Homayoun 2007; Rolls & Grabenhorst 2008). 
Importantly, this pattern of dissociation between cortical structures extends to 
dopaminergic transmission. In humans with Parkinson’s Disease, L-DOPA 
treatment impaired performance in an OFC-dependent gambling task, but 
improved performance in a set shifting task that relies on dorsolateral prefrontal 
cortex, a structure that appears to be functionally analogous to rodent mPFC 
(Brown & Bowman 2002; Cools et al. 2003; Uylings et al. 2003). Even more 
relevant is the fact that the D2 agonist bromocriptine produced opposite effects 
on cognitive tasks mediated by these two different prefrontal cortical regions, 
impairing OFC-dependent reversal learning and enhancing dorsolateral 
prefrontal cortex dependent working memory (Mehta et al. 2001). Therefore, the 
heterogeneity of dopaminergic (and specifically D2-related) neurotransmission 
within different prefrontal cortical structures found here is not without precedent. 
The interaction between these different but interconnected systems may be a 
critical component of the development of behavioral biases either toward or away 
from risky choice. Studies utilizing contralaterally placed lesions or 
electrophysiological recording could be used to elucidate the specific nature of 
this functional relationship.   
Striatal Dopaminergic Mediation of Risky Decision-making 
 A relationship was also observed between D2 receptor expression in DS 
and risky decision-making. As with OFC, this relationship was a non-linear 
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function, although the pattern of results was different; in that risk-averse rats 
displayed greater D2 mRNA than both moderate-risk and risk-taking rats. The 
involvement of DS in risky decision-making is particularly interesting, as DS has 
been traditionally associated with habitual learning and memory rather than 
complex behavior based on multiple cues and contingencies (Everitt et al. 2008; 
Packard 2009). The current findings, along with recent sentiment that DS may in 
fact contribute to action selection and flexible decision-making (Balleine et al. 
2007; Johnson et al. 2007), suggest DS as a region that may play a pivotal role 
in the cost-benefit decision-making process.  
These data complemented the results obtained in Experiment 2, as 
enhanced D2 receptor expression in DS was associated with attenuated risky 
choice. This suggests that enhanced D2 receptor binding in DS may be 
responsible for amphetamine and bromocriptine’s effects on risky decision-
making. However, it is important to note that both OFC and mPFC, in which D2 
levels also were associated with risk, are functionally connected to DS as well as 
each other (Berendse et al. 1992; Ragozzino 2007). Therefore, it is more likely 
that a dopamine-modulated circuit consisting of these structures (and likely 
others as well) contributes collectively to the risky decision-making process.  
 NAcc D2 expression was not associated with risky decision-making 
performance. This is somewhat surprising because NAcc is involved with the 
representation of both rewarding and aversive outcomes (Schoenbaum & Setlow 
2003; Setlow et al. 2003), both of which are factors in the risky decision-making 
task. Additionally, NAcc has been found to mediate performance in several other 
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cost-benefit decision-making tasks (Cardinal & Howes 2005; Cardinal et al. 2001; 
Hauber & Sommer 2009). While this study provides evidence that baseline D2 
receptor expression in NAcc does not strongly influence risky decision-making, 
further work is necessary to determine if an intact NAcc is required for risky 
decision-making, or if other neurotransmitters (or dopamine receptor subtypes) 
within NAcc mediate risky choice.  
The Relationship between D2 Receptors and Other Forms of Cost-benefit 
Decision-making 
  Probabilistic discounting performance displayed a modest negative 
correlation with D2 expression in OFC, indicating that enhanced preference for 
higher risk of reward omission (i.e., “gambling” behavior) was associated with 
lower levels of D2 receptor availability. This is somewhat surprising, as mPFC 
rather than OFC has typically been implicated in probabilistic discounting 
performance (Cardinal 2006; St. Onge & Floresco In Press). However, it is 
important to note that the observed correlation and differences between groups 
were both contingent on the probabilistic discounting performance of three 
specific subjects, all of which exceeded 2 standard deviations from the group 
mean (Figure 19). Thus, replication using more subjects may be necessary 
before making strong inferences using these data.  
The lack of a relationship between OFC or NAcc D2 expression and delay 
discounting is somewhat surprising, as OFC and NAcc rather than mPFC have 
traditionally been implicated in delay discounting (Cardinal et al. 2001; Roesch et 
al. 2006; Rudebeck et al. 2006; Winstanley et al. 2004b). Dopamine transmission 
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has also been associated with impulsivity and delay perception (Cardinal et al. 
2000; Winstanley et al. 2005), and dopamine in OFC has specifically been 
associated with impulsive choice, as dopamine depletion localized to OFC 
decreases impulsive choice (increasing choice of the larger delayed reward) 
(Kheramin et al. 2004). It is possible that delay discounting is mediated by other 
dopaminergic receptor subtypes, although it has been observed that systemic D2 
rather than D1 antagonists increase impulsive choice (Wade et al. 2000). 
Another possibility is that, while extreme shifts in dopamine neurotransmission 
induced by direct or indirect agonists can influence impulsive choice, the 
relatively small baseline differences in D2 expression in OFC and NAcc do not 
produce substantial variations in impulsive choice.  
In contrast with the results in OFC and NAcc, delay discounting 
performance was associated with D2 expression in mPFC, such that rats with 
either high or low levels of impulsivity both displayed higher expression of D2 
mRNA than rats with moderate levels of impulsive choice. While not as well 
studied as OFC with regard to delay discounting, there are recent data showing 
that mPFC inactivation can increase impulsive choice (Churchwell et al. 2009). 
Additionally, enhancements in dopamine and dopamine metabolites have been 
observed in mPFC during delay discounting, although this same increase 
occurred in a yoked group, implying that dopamine in mPFC may mediate 
motivational processes rather than reward choice. As mentioned earlier mPFC is 
reciprocally connected to OFC (Moghaddam & Homayoun 2007); therefore, D2 
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receptor expression in mPFC may affect impulsive choice indirectly by 
influencing OFC function, possibly via dopaminergic mechanisms. 
The Relationship between D2 Receptors and Other Behavioral Measures 
 A relationship was uncovered between impulsive action and D2 
expression in NAcc such that highly impulsive rats expressed less D2 mRNA 
than rats with lower impulsivity. This replicated a previous study which reported 
that reduced D2 receptor availability predicts a high impulsive phenotype in rats 
(Dalley et al. 2007). Additionally, a relationship was also observed between 
mPFC D2 expression and impulsive action such that highly impulsive rats 
expressed less baseline D2 receptor mRNA in mPFC than low impulsive rats. 
This is not surprising, as lesions of mPFC induce a variety of deficits in impulsive 
action, including excessive premature responding (the measure utilized here). It 
is likely that NAcc and mPFC act in concert to regulate impulsive action, as 
intracranial infusions of the D2/D3 antagonist sulpiride into NAcc ameliorated the 
mPFC lesion deficits (Pezze et al. 2009).     
 A negative linear relationship was revealed between mPFC D2 expression 
and sucrose consumption such that rats with increased D2 expression in mPFC 
demonstrated lower consummatory motivation. This seems counterintuitive, as 
the D2 agonist quinpirole enhances drinking behavior to a near-compulsive 
degree (Amato et al. 2007; Fraiolo et al. 1997). Additionally, it has been observed 
that during feeding behavior, a dopamine efflux occurs in both mPFC and NAcc 
that gradually decreases as satiety ensues (Ahn & Phillips 2002). Because we 
observed here that increased D2 expression in mPFC predicts lower levels of 
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feeding, it is possible that dopamine signaling in mPFC during consumption may 
be exerting an inhibitory influence, possibly mediated by D2 receptors.  
 A negative correlation was discerned between D2 expression in mPFC 
and multiple measures of spontaneous locomotion. The finding that high baseline 
levels of D2 expression predict lower locomotion is not entirely surprising; direct 
infusions of the D2 agonist quinpirole into mPFC blocks both acute and 
sensitized cocaine-induced locomotor enhancement (Beyer & Steketee 2002). 
Additionally, a contributing factor to drug induced locomotor sensitization (which 
results in increased locomotor responses to drugs and novel stimuli) is a 
decrease in D2 receptor availability, which reduces the mPFC’s inhibitory 
influence over NAcc (Kalivas et al. 2005). Therefore, an increase in the inhibitory 
power of mPFC via higher D2 receptor availability (which, presumably, would 
result from enhanced D2 expresssion) would be expected to reduce spontaneous 
locomotor activity.   
Experiment 3 Summary 
 Relationships between D2 dopamine receptor expression and risky 
decision-making behavior were revealed in multiple brain regions. In OFC, D2 
expression was greater for both risk-taking and risk-averse rats than in 
moderately risky rats. Conversely, in mPFC D2 expression was higher for 
moderate risky rats and lower for the other groups. The opposing patterns of 
results between interconnected regions resemble the heterogeneity observed 
between these structures in other contexts (Moghaddam & Homayoun 2007; 
Robbins 2005) , and further experimentation is necessary to delineate how these 
93 
 
reciprocal circuits interact to guide risky behavior. Importantly, the nonlinear 
patterns of results observed in both OFC and mPFC were not entirely surprising, 
as dose-response curves to pharmacological treatment (including dopamine) 
during prefrontal cortical reliant tasks are often manifested as U- or inverted U- 
shaped behavioral trends (Robbins 2005). 
 A different pattern of results was observed in DS, with the risk-averse 
group displaying a higher abundance of mRNA expression than the other, riskier 
groups. These data coincide with the results from Experiment 2, during which 
rats administered the D2 agonist bromocriptine exhibited a profound attenuation 
in risky choice. Thus, it is a possibility that DS is the brain region most directly 
affected by bromocriptine (and amphetamine) that mediates the shift away from 
risky choice. These data are particularly exciting, as DS has largely been 
overlooked as a substrate of cost-benefit decision-making. 
 Relationships were also observed between D2 expression in OFC and 
probabilistic discounting, as well as between D2 expression in mPFC and delay 
discounting. Importantly, rats that demonstrated high impulsive action also 
displayed reduced D2 expression in NAcc, which was theoretically consistent 
with Dalley et al. (2007).  
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SUMMARY AND CONCLUSIONS 
 
 In Experiment 1, evidence was provided that risky decision-making 
behavior in rats exists as a behavioral trait separate from general motivation, 
anxiety, pain tolerance, or other decision-making processes. The risky decision-
making task has been shown to be reliable (Simon et al. 2009), and groups of 
rats consistently display a widespread range of performance, which renders this 
task especially useful for examining the biological substrates underlying 
individual differences (as in Experiment 3). These data support the utility of the 
risky decision-making task for further study of both the cause of and treatments 
for excessive, maladaptive risky choice. 
 Experiment 2 demonstrated that acute amphetamine can attenuate risky 
choice, and that D2 dopamine receptors are necessary and sufficient for this 
effect. Experiment 3 expanded on the finding that D2 receptors mediate risky 
behavior by comparing baseline levels of D2 mRNA expression with performance 
in the risky decision-making task. Risky decision-making behavior predicted 
levels of D2 mRNA hybridization in both orbitofrontal cortex and medial prefrontal 
cortex, although these brain regions displayed opposite trends, with orbitofrontal 
cortex D2 hybridization showing a U-shaped relationship with risky choice, and 
medial prefrontal cortex D2 hybridization resembling an inverted U-curve. 
Additionally, increased levels of D2 mRNA in dorsal striatum were observed in 
risk-averse rats in comparison to risk-taking rats. These data suggest the 
involvement of a corticostriatal circuit in risky decision-making. 
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These experiments provide a foundation for an understanding of how 
dopaminergic transmission acts to regulate risky and impulsive behavior. This is 
especially important because disorders such as Parkinson’s disease, Dopamine 
dysregulation syndrome, and Restless Leg Syndrome require direct or indirect 
dopamine agonist treatment, and this treatment often induces near compulsive 
levels of risky and impulsive behavior (Antonini & Cilia 2009; Pourcher et al. ; 
Wolters et al. 2008). Risk assessment tasks such as the risky decision-making 
tasks could be utilized to determine by which action these dopaminergic drugs 
are inducing such behavioral abnormalities, and what measures could be taken 
to alleviate these problems. 
Decision-making is rarely a black and white process: subjectively 
rewarding outcomes often require some form of expense, be it the requirement of 
hard work, the possibility of a hazardous outcome, or the relinquishment of other 
benefits. The risky decision-making task is a particularly effective model of 
complex decision-making because it adheres to this concept, offering two options 
without a clear cut “correct” answer. This ambiguous nature of this task is likely 
accountable for the wide variance observed, with rats’ performance ranging from 
complete avoidance of the risky reward lever to consistent selection of the risky 
reward regardless of punishment probability. Perhaps the most striking 
observation from this study was the number of trends in D2 dopamine receptor 
expression that were shared by both risk-averse and risk-taking rats. It is 
interesting to consider that, in some situations, an inability to take risks may be 
equally as maladaptive as excessive risk taking. The risky decision-making task 
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offers a reliable and valid method of assessing robust individual differences, 
testing pharmacological agents, and uncovering the neural networks that 
integrate risks and rewards. 
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